The Home Infusion Therapy Devices Market is anticipated to reach US$ 2.3 billion in 2023 and US$ 4.4 billion in 2033. Sales of home infusion therapy equipment are anticipated to increase significantly over the course of the forecast period, at a CAGR of 6.6%. The use of home infusion treatment equipment is expanding along with …
Category Archives: Healthcare Trends
DNA Methylation Market is expected to reach US$ 5815.49 Million by 2033, at a CAGR of 15%
According to Future Market Insights, the DNA Methylation Market demand is expected to grow at a 15% CAGR between 2023 and 2033. The global market for DNA methylation is expected to reach US$ 5815.49 million by 2033. In addition, the rising prevalence of esophageal adenocarcinoma has contributed to the overall increase. According to the American …
Endocrine Testing Market Overview 2023 to 2033 | By bioMerieux SA, DiaSorin S.p.A, AB Sciex, Ortho Clinical Diagnostics
The global Endocrine Testing Market size is presently worth US$ 2536.7 million and is predicted to develop at an 8.5% CAGR over the forecast period. Diabetes cases are expected to grow, resulting in a market value of US$ 5735 million by 2032. Endocrine issues have become more common in the last five years, along with …
Insulin Pens Market is forecasted to surpass US$ 66 billion grow at 6.5% CAGR from 2023 to 2033
The global Insulin Pens Market is expected to grow at a CAGR of 6.5% during the period 2023-2033. The market is holding a valuation of US$ 35 billion as of 2023. The market is projected to be valued at US$ 66 billion by 2033. According to Future Market Insights (FMI), the demand for insulin pens is expected to rise considerably in the coming …
Advanced Empty Capsule Market is likely to exceed a valuation of US$ 5.04 Billion grow at a CAGR of 6.2% through 2032
In 2022, the adoption of sophisticated empty capsules is anticipated to be valued at US$2.76 billion. By 2032, it is predicted that sales of Advanced Empty Capsule Market will surpass a valuation of US$ 5.04 billion. Through 2032, the market for sophisticated empty capsules is anticipated to expand at a CAGR of 6.2%. Pharmaceutical manufacturers …
U.S. Digital Ovulation Test Kits Market is likely to exceed a valuation of US$ 162.7 Million grow at a CAGR of 9.6% through 2032
By 2032, sales of U.S. Digital Ovulation Test Kits Market are forecast to be worth more than US$ 162.7 million. Through 2032, the market for digital ovulation test kits is anticipated to expand at a CAGR of 9.6%. Digital ovulation tests help women to maximize the chances of conceiving naturally by identifying the two most …
Pharmaceutical Caps and Closures Market is projected to reach US$ 4 Billion by 2032 at a CAGR of 5.7%
By the end of 2021, the Pharmaceutical Caps and Closures Market is expected to cross US$ 2.27 billion in value, according to Future Market Insights (FMI). By 2032, it is expected that the pharmaceutical caps and closures market would generate $4 billion in revenue. From 2022 to 2032, the pharmaceutical caps and closures market is …
United Kingdom Surface Disinfectants Market is projected to reach US$ 526.7 Million by 2033
The Surface Disinfectants Market is projected to generate US$ 8.1 billion in 2023. The market for surface disinfectants is projected to increase to more than US$ 16.4 billion over the next 10 years, according to Future Market Insights’ (FMI) assessment. The market was predicted to expand at a 7.3% CAGR between 2023 and 2033. The Surface …
Single Dose Radiotherapy Services Market to grow at 6.1% CAGR through 2030
A single dosage of radiation is claimed to be a safe and efficient treatment for men with low-risk prostate cancer in the Single Dose Radiotherapy Services Market since it is given directly to the tumour in a matter of minutes. Future Market Insights (FMI) predicts that by 2021, the market for single-dose therapy would have …
Continue reading “Single Dose Radiotherapy Services Market to grow at 6.1% CAGR through 2030”
APOL1 Mediated Kidney Disease Market is expected to garner a value of USD 5753.9 million and expand at a 4.3% value CAGR by 2033
The APOL1 Mediated Kidney Disease Market is anticipated to reach a worth of USD 3779.9 million in 2023 before increasing to USD 5753.9 million by 2033, with a forecasted CAGR of 4.3%. The current alternatives for treatment are few, and they only work to treat the signs of APOL1 Mediated Kidney Disease Market disorders, such …